Prehypertension is the category of blood pressure (BP) defined as systolic BP between
120 and 139 mmHg and diastolic BP between 85 and 89 mmHg. Prehypertension is a continuum
to hypertension and is emerging as an important risk factor for cardiovascular disease.
The definition of the cardiometabolic syndrome is a cluster of several risk factors
such as abdominal obesity, prehypertension or hypertension, dyslipidemia and prediabetes.
Prevention by lifestyle intervention and also treatment of individual components is
recommended, given that most subjects with metabolic syndrome fall into the high-risk
category. There are several studies with dietary approaches, which showed that these
approaches helped in stopping the progression of hypertension and also improved the
metabolic conditions. Several large trials are under way to study several antihypertensive
drugs to delay the development of hypertension. Identifying early cardiovascular disease
in asymptomatic individuals provides a better guide to the need for individualized
preventive therapy than traditional risk factor assessment.